Clinics in countries that accept the CE mark will soon begin to use MeMed's groundbreaking MeMed BV test following the partnered launch announced 23 November.
The test will be run on DiaSorin’s Liaison point-of-care (PoC) testing platform, alongside its current tests, which include Sars-CoV-2, rheumatology and gastroenterology applications
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?